Woodline Partners LP 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Woodline Partners LP | 2,114,056 2.400% |
-2,226,284 (-51.29%) |
Filing |
| 2024-11-14 1:01 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Woodline Partners LP | 4,340,340 5.700% |
4,340,340 (New Position) |
Filing |